Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $13.26 billion. The enterprise value is $14.98 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 184.77 million shares outstanding. The number of shares has increased by 2.11% in one year.
| Current Share Class | 184.77M |
| Shares Outstanding | 184.77M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 103.39% |
| Float | 183.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.96 |
| Forward PS | 4.26 |
| PB Ratio | 4.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.87.
| Current Ratio | 2.17 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.01 |
Financial Efficiency
Return on equity (ROE) is -5.60% and return on invested capital (ROIC) is -3.04%.
| Return on Equity (ROE) | -5.60% |
| Return on Assets (ROA) | -2.71% |
| Return on Capital (ROIC) | -3.04% |
| Revenue Per Employee | $395,759 |
| Profits Per Employee | -$26,516 |
| Employee Count | 6,600 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.43 |
Taxes
In the past 12 months, Exact Sciences has paid $2.91 million in taxes.
| Income Tax | 2.91M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.13% in the last 52 weeks. The beta is 1.27, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +6.13% |
| 50-Day Moving Average | 67.00 |
| 200-Day Moving Average | 58.90 |
| Relative Strength Index (RSI) | 57.95 |
| Average Volume (20 Days) | 1,413,028 |
Short Selling Information
The latest short interest is 15.54 million, so 8.41% of the outstanding shares have been sold short.
| Short Interest | 15.54M |
| Short Previous Month | 14.03M |
| Short % of Shares Out | 8.41% |
| Short % of Float | 8.47% |
| Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.61 billion and -$175.01 million in losses. Loss per share was -$0.96.
| Revenue | 2.61B |
| Gross Profit | 1.91B |
| Operating Income | -282.27M |
| Pretax Income | -172.10M |
| Net Income | -175.01M |
| EBITDA | -68.90M |
| EBIT | -282.27M |
| Loss Per Share | -$0.96 |
Full Income StatementBalance Sheet
The company has $946.78 million in cash and $2.78 billion in debt, giving a net cash position of -$1.84 billion or -$9.94 per share.
| Cash & Cash Equivalents | 946.78M |
| Total Debt | 2.78B |
| Net Cash | -1.84B |
| Net Cash Per Share | -$9.94 |
| Equity (Book Value) | 3.19B |
| Book Value Per Share | 17.29 |
| Working Capital | 783.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $118.66 million and capital expenditures -$133.62 million, giving a free cash flow of -$14.96 million.
| Operating Cash Flow | 118.66M |
| Capital Expenditures | -133.62M |
| Free Cash Flow | -14.96M |
| FCF Per Share | -$0.08 |
Full Cash Flow StatementMargins
Gross margin is 73.19%, with operating and profit margins of -10.81% and -6.70%.
| Gross Margin | 73.19% |
| Operating Margin | -10.81% |
| Pretax Margin | -6.59% |
| Profit Margin | -6.70% |
| EBITDA Margin | -2.64% |
| EBIT Margin | -10.81% |
| FCF Margin | -0.57% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.11% |
| Shareholder Yield | -2.11% |
| Earnings Yield | -1.33% |
| FCF Yield | -0.11% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $79.92, which is 11.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $79.92 |
| Price Target Difference | 11.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 12.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.74 |
| Piotroski F-Score | 3 |